Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pernicious anemia in Turkey.

R Kocak1, S Paydas

  • 1Cukurova University School of Medicine, Department of Hematology, Balcali-Adana, Turkey.

International Journal of Hematology
|April 1, 1992
PubMed
Summary

Pernicious anemia diagnoses in Turkey revealed a younger patient population compared to US demographics. This study highlights potential variations in pernicious anemia presentation across different populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the effectiveness of liposomal doxorubicin and gemcitabine in patients with platinum-sensitive recurrent ovarian cancer receiving third-line chemotherapy.

European review for medical and pharmacological sciences·2023
Same author

Comparison of different cyclin-dependent kinase inhibitors and KI-67 levels on survival and toxicity in breast cancer treatment.

European review for medical and pharmacological sciences·2023
Same author

Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes.

Cancer chemotherapy and pharmacology·2018
Same author

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.

Transplantation proceedings·2016
Same author

Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Area of Science:

  • Hematology
  • Internal Medicine
  • Epidemiology

Background:

  • Pernicious anemia is a condition affecting vitamin B12 absorption.
  • Demographic variations in pernicious anemia prevalence and age of onset are documented globally.
  • Understanding patient demographics is crucial for disease management and research.

Purpose of the Study:

  • To analyze the demographic characteristics of pernicious anemia patients diagnosed at a Turkish university hospital.
  • To compare the findings with existing data from other populations, particularly the United States.

Main Methods:

  • Retrospective review of patient records diagnosed with pernicious anemia over a 5-year period.
  • Data collection included patient demographics such as age and sex.
  • Statistical analysis of mean age and comparison with international cohorts.

Main Results:

  • 44 patients were diagnosed with pernicious anemia.
  • The patient cohort comprised 30 males and 14 females.
  • The mean age of diagnosis was lower than reported for White, Black, and Hispanic populations in the US, with specific mean ages for males (49.14) and females (40.00).

Conclusions:

  • Pernicious anemia patients in this Turkish cohort were diagnosed at a younger mean age compared to US populations.
  • This suggests potential ethnic or geographic variations in the clinical presentation of pernicious anemia.
  • Further research is warranted to explore the factors contributing to these demographic differences.

Related Experiment Videos